Skip to main content

Advertisement

SpringerLink
Log in

Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand?

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Purpose

Fifty years ago, Bolande described Congenital Mesoblastic Nephroma (CMN) as a benign lesion. Unexpected aggressive clinical behaviors prompted a sub-classification based on histology. Recent molecular genetic evidence has identified the aggressive cellular variant to be the renal manifestation of congenital infantile fibrosarcoma. We submit a reappraisal and analysis of the available literature on recurrent and metastatic CMN.

Methods

An electronic search of PubMed, MEDLINE, EMBASE, and Scopus yielded 38 children with local recurrence and/or metastases.

Results

Of the 38 children with local recurrence and/or metastasis, 59% were girls. Median time to recurrence was 6 months (range 1–12 months). The commonest sites of metastases were the lung (39%) and liver (29%). Fifty percent of these children died of disease. The outcome of additional chemotherapy (p = 0.5) did not differ from that of surgery alone. The choice of chemotherapy did not influence the outcome (p = 0.6).

Conclusions

Recurrence and metastasis in cellular CMN are much more common than described earlier and carry a high mortality. Children with cellular and mixed CMN require close clinical and radiological follow-up for a minimum of 12 months after primary surgery. Surgery is the mainstay of the treatment of recurrent and metastatic lesions. Neoadjuvant chemotherapy is recommended only if the lesion is inoperable. Targeted therapy may be an option in treatment of refractory cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bolande RP, Borough AJ, Izant RJ Jr (1967) Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms’ tumor. Paediatrics 40:272–278

    CAS  Google Scholar 

  2. Walker D, Richard GA (1973) Fetal hamartoma of the kidney: recurrence and death of patient. J Urol 110:352–353

    Article  CAS  PubMed  Google Scholar 

  3. Heidelberger KP, Ritchey ML, Dauser RC, McKeever PE, Beckwith JB (1993) Congenital mesoblastic nephroma metastatic to the brain. Cancer 72:2499–2502

    Article  CAS  PubMed  Google Scholar 

  4. Joshi V, Kasznica J, Walters T (1986) A typical mesoblastic nephroma. Arch Pathol Lab Med 110:100–106

    CAS  PubMed  Google Scholar 

  5. Sandberg AA, Bridge JA (2002) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: congenital (infantile) fibrosarcoma and mesoblastic nephroma. Cancer Genet Cytogenet 132:1–13

    Article  CAS  PubMed  Google Scholar 

  6. Tognon C, Garnett M, Kenward E, Kay R, Morrison K, Sorensen PH (2001) The chimeric protein tyrosine kinase ETV6–NTRK3 requires both Ras-Erk1/2 and PI3- kinase-Akt signaling for fibroblast transformation. Cancer Res 61:8909–8916

    CAS  PubMed  Google Scholar 

  7. Patel Y, Mitchell CD, Hitchcock RJ (2003) Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases. Urology 61:1260

    Article  PubMed  Google Scholar 

  8. Furtwaengler R, Reinhard H, Leuschner I, Schenk JP, Goebel U, Claviez A et al (2006) Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH) Nephroblastoma Study Group. Mesoblastic nephroma—A report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH). Cancer 106:2275–2283

    Article  PubMed  Google Scholar 

  9. Gooskens SL, Houwing ME, Vujanic GM, Dome JS, Diertens T, Coulomb-l’Herminé A et al (2017) Congenital mesoblastic nephroma 50 years after its recognition: a narrative review. Pediatr Blood Cancer. doi:10.1002/pbc.26437

    PubMed  Google Scholar 

  10. Howell CG, Othersen HB, Kiviat NE, Norkool P, Beckwith JB, D’Angio GJ (1982) Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms’ Tumor Study. J Pediatr Surg 17:826–831

    Article  CAS  PubMed  Google Scholar 

  11. Steinfeld AD, Crowley CA, O’Shea PA, Tefft M (1984) Recurrent and metastatic mesoblastic nephroma in infancy. J Clin Oncol 2:956–960

    Article  CAS  PubMed  Google Scholar 

  12. Joshi VV, Kay S, Milsten R, Koontz WW, McWilliams NB (1973) Congenital mesoblastic nephroma of infancy: report of a case with unusual clinical behavior. Am J Clin Pathol 60:811–816

    Article  CAS  PubMed  Google Scholar 

  13. Chellama VG, Chacko E (1986) Congenital mesoblastic nephroma study of 7 cases–report of a case of atypical mesoblastic nephroma. Indian J Cancer 23:238–246

    CAS  PubMed  Google Scholar 

  14. Chan HS, Cheng MY, Mancer K, Payton D, Weitzman SS, Kotecha P, Daneman A (1987) Congenital mesoblastic nephroma: a clinicoradiologic study of 17 cases representing the pathologic spectrum of the disease. J Pediatr 111:64–70

    Article  CAS  PubMed  Google Scholar 

  15. Ali AA, Finlay JL, Gerald WL, Nisen P, Rosenfield NS, LaQuaglia MP, Spillman M, O’Mally B, Fraser R (1994) Congenital mesoblastic nephroma with metastasis to the brain: a case report. Am J Pediatr Hematol Oncol 16:361–364

    CAS  PubMed  Google Scholar 

  16. Sane SY, Badhe PB, Kulkarni BK (1996) A typical mesoblastic nephroma. A potentially malignant variant of congenital mesoblastic nephroma. Review of literature and report of four cases. Indian J Cancer 33:6–11

    CAS  PubMed  Google Scholar 

  17. Loeb DM, Hill DA, Dome JS (2002) Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy. J Pediatr Hematol Oncol 24:478–481

    Article  PubMed  Google Scholar 

  18. Bayindir P, Guillerman RP, Hicks MJ, Chintagumpala MM (2009) Cellular mesoblastic nephroma (infantile renal fibrosarcoma): institutional review of the clinical, diagnostic imaging, and pathologic features of a distinctive neoplasm of infancy. Pediatr Radiol 39:1066–1074

    Article  PubMed  Google Scholar 

  19. Ko SM, Kim MJ, Im YJ, Park KI, Lee MJ (2013) Cellular mesoblastic nephroma with liver metastasis in a neonate: prenatal and postnatal diffusion-weighted MR imaging. Korean J Radiol 14:361–365

    Article  PubMed  PubMed Central  Google Scholar 

  20. Jones VS, Cohen RC (2007) Atypical congenital mesoblastic nephroma presenting in the perinatal period. Pediatr Surg Int 23:205–209

    Article  PubMed  Google Scholar 

  21. Wang ZP, Li K, Dong KR, Xiao XM, Zheng S (2014) Congenital mesoblastic nephroma: clinical analysis of eight cases and a review of the literature. Oncol Lett 8:2007–2011

    PubMed  PubMed Central  Google Scholar 

  22. Chaudry G, Perez-Atayde AR, Ngan BY, Gundogan M, Daneman A (2009) Imaging of congenital mesoblastic nephroma with pathological correlation. Pediatr Radiol 39:1080–1086

    Article  PubMed  Google Scholar 

  23. Gaillard D, Bouvier R, Sonsino E, Boccon Gibod L, Jaubert F, Nezelof C et al (1992) Nucleolar organizer regions in congenital mesoblastic nephroma. Pediatr Pathol 12:811–821

    Article  CAS  PubMed  Google Scholar 

  24. Schlesinger AE, Rosenfield NS, Castle VP, Jasty R (1995) Congenital mesoblastic nephroma metastatic to the brain: a report of two cases. Pediatr Radiol 25(Suppl 1):73–75

    Google Scholar 

  25. Gonzalez-Crussi F, Sotelo-Avila C, Kidd JM (1995) Malignant mesenchymal nephroma of infancy: report of a case with pulmonary metastases. Am J Surg Pathol 4:185–190

    Article  Google Scholar 

  26. Argani P, Fritsch M, Kadkol SS, Schuster A, Beckwith JB, Perlman EJ (2000) Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol 13:29–36

    Article  CAS  PubMed  Google Scholar 

  27. Bell MG, Goodman TR (2002) Perinephric cystic mesoblastic nephroma complicated by hepatic metastases: a case report. Pediatr Radiol 32:829–831

    Article  PubMed  Google Scholar 

  28. Watanabe N, Haruta M, Soejima H, Fukushi D, Yokomori K, Nakadate H et al (2007) Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type. Genes Chromosomes Cancer 46:929–935

    Article  CAS  PubMed  Google Scholar 

  29. Vujanic GM, Delemarre JF, Moeslichan S, Lam J, Harms D, Sandstedt B et al (1993) Mesoblastic nephroma metastatic to the lungs and heart—another face of this peculiar lesion: case report and review of the literature. Pediatr Pathol 13:143–153

    Article  CAS  PubMed  Google Scholar 

  30. Santos LG, Carvalho Jde S, Reis MA, Sales RL (2011) Cellular congenital mesoblastic nephroma: case report. J Bras Nefrol 33:109–112

    Article  PubMed  Google Scholar 

  31. Wang Y, Esebua M (2014) Congenital mesoblastic nephroma: two case studies and review of literature. Am J Clin Pathol 142:A281

    Article  Google Scholar 

  32. Gunes A, Oguz B, Ozcan N, Kologlu M, Orhan D, Yalcın Ankara B (2015) Peritoneal metastasis of congenital mesoblastic nephroma. Pediatr Radiol 45:S247–S368

    Article  Google Scholar 

  33. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184–187

    Article  CAS  PubMed  Google Scholar 

  34. Orbach D, Rey A, Cecchetto G, Oberlin O, Casanova M, Thebaud E et al (2010) Infantile fibrosarcoma: management based on the European experience. J Clin Oncol 28:318–323

    Article  PubMed  Google Scholar 

  35. McCahon E, Sorensen PH, Davis JH, Rogers PC, Schultz KR (2003) Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. Med Pediatr Oncol 40:288–292

    Article  PubMed  Google Scholar 

  36. Chan KL, Chan KW, Lee CW, Saing H (1995) Preoperative chemotherapy for mesoblastic nephroma. Med Pediatr Oncol 24:271–273

    Article  CAS  PubMed  Google Scholar 

  37. Wong V, Pavlick D, Brennan T, Yelensky R, Crawford J, Ross JS et al (2015) Evaluation of a congenital infantile fibrosarcoma by comprehensive genomic profiling reveals an LMNA-NTRK1 gene fusion responsive to crizotinib. J Natl Cancer Inst. doi:10.1093/jnci/djv307

    Google Scholar 

  38. Pavlick D, Schrock AB, Malicki D, Stephens PJ, Kuo DJ, Ahn H et al (2017) Identification of NTRK fusions in pediatric mesenchymal tumors. Pediatr Blood Cancer. doi:10.1002/pbc.26433

    PubMed  Google Scholar 

  39. Laetsch TW, Nagasubramanian R, Casanova M (2017) Targeting NTRK fusions for the treatment of congenital mesoblastic nephroma. Pediatr Blood Cancer. doi:10.1002/pbc.26593

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatric Surgery, The Children’s Hospital at Westmead, Sydney Medical School, The University of Sydney, Cnr Hawkesbury Road and Hainsworth Street, Westmead, NSW, 2145, Australia

    Susan Jehangir, Dharshini Selvarajah & Andrew J. A. Holland

  2. Department of Pediatric Surgery, Christian Medical College, Vellore, Tamil Nadu, India

    Jujju J. Kurian & Reju J. Thomas

Authors
  1. Susan Jehangir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jujju J. Kurian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dharshini Selvarajah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reju J. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrew J. A. Holland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew J. A. Holland.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jehangir, S., Kurian, J.J., Selvarajah, D. et al. Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand?. Pediatr Surg Int 33, 1183–1188 (2017). https://doi.org/10.1007/s00383-017-4149-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-017-4149-5

Keywords

Search

Navigation